Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA - eviltoast
GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.
  • akrz@programming.dev
    2·
    1 year ago

    This is only if you opted into research. And I am actually happy this is happening. If only one person is helped by research outcomes or medications developed from this, I am happy. I don’t care if 23andMe gets rich from it or not.